ChemicalBook--->CAS DataBase List--->2196243-57-7

2196243-57-7

2196243-57-7 Structure

2196243-57-7 Structure
IdentificationBack Directory
[Name]

USP7-IN-4
[CAS]

2196243-57-7
[Synonyms]

USP7-IN-4
[Molecular Formula]

C29H34N6O3
[MOL File]

2196243-57-7.mol
[Molecular Weight]

514.62
Chemical PropertiesBack Directory
[Boiling point ]

775.3±70.0 °C(Predicted)
[density ]

1.31±0.1 g/cm3(Predicted)
[pka]

13.39±0.20(Predicted)
Hazard InformationBack Directory
[Description]

USP7-IN-4 is a highly potent and selective allosteric USP7 inhibitor.
[Uses]

USP7-IN-2 (compound 4) is a non-competitive USP7 inhibitor with an IC50 of 6 nM. USP7-IN-2 causes degradation of MDM2, stabilization of p53 and induction of p21 in multiple cell lines, and can be utilized in cancer research[1].
[References]

[1] Gavory G, et al. Discovery and characterization of highly potent and selective allosteric USP7 inhibitors. Nat Chem Biol. 2018 Feb;14(2):118-125. DOI:10.1038/nchembio.2528
Spectrum DetailBack Directory
[Spectrum Detail]

USP7-IN-4(2196243-57-7)1HNMR
2196243-57-7 suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: Nanjing Shizhou Biology Technology Co.,Ltd  
Tel: 025-85560043 15850508050
Website: http://www.synzest.com
Tags:2196243-57-7 Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.